Aurinia Pharmaceuticals to Release Fourth Quarter and Year End 2021 Financial Results on February 28, 2021
February 09 2022 - 4:17PM
Business Wire
Aurinia Pharmaceuticals Inc. (NASDAQ: AUPH) (the “Company”)
today announced that it will release its fourth quarter and year
end 2021 financial results on Monday, February 28, 2021, before
markets open. Aurinia’s management team will host a conference
call/webcast at 8:30 am ET that day to review the Company’s 2021
financial results, provide a general business update and discuss
the Company’s outlook for 2022.
Interested participants can dial +1-877-407-9170
(Toll-free U.S. & Canada). The audio webcast can also be
accessed under "News/Events” through the “Investors” section of the
Aurinia corporate website at www.auriniapharma.com. A replay of the
webcast will be available on Aurinia’s website.
ABOUT AURINIA
Aurinia is a fully integrated biopharmaceutical company focused
on delivering therapies to treat targeted patient populations that
are impacted by serious diseases with a high unmet medical need. In
January 2021, the Company introduced the first FDA-approved oral
therapy indicated for the treatment of adult patients with active
lupus nephritis (LN). Aurinia’s head office is in Victoria, British
Columbia; its U.S. commercial hub is in Rockville, Maryland; and
the Company focuses development efforts globally.
View source
version on businesswire.com: https://www.businesswire.com/news/home/20220209005894/en/
Investor and Corporate Contact: Dana Lynch, IR &
Corporate Communications dlynch@auriniapharma.com
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Aug 2024 to Sep 2024
Aurinia Pharmaceuticals (NASDAQ:AUPH)
Historical Stock Chart
From Sep 2023 to Sep 2024